FDA Investigator Raymond Souweha
Raymond Souweha has conducted inspections on 29 sites in 1 countries as of 03 Nov 2003. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
29
Last Inspection Date:
03 Nov 2003
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Raymond Souweha:
Andrew B Slarve,
Andrew T Todd,
Angel K Sandhu,
Angela D Wise,
Anna L Marroquin,
Benny Y Gong,
Bruce D Broidy,
Carl Lee,
Carrie E Thrasher,
Celeste K Wong,
Chloe Anne Leong,
Christine M Parmentier,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Daniel J Simonsen,
Daniel Velasquez,
Darla R Bracy,
David A Lum,
Edna J Hidalgo,
Elodie X Tong Lin,
Emal Wahab,
Eric J Heinze,
Eric W Anderson,
Erica R Pomeroy,
Estefania Fernandez,
Gillenwater,
Gulshan R Anand,
Helen J Hamaoka,
Huy T Pham,
Indigo A Doll,
Ingrid A Zambrana,
James C Yee,
Janice K Gardner,
Janice R Small,
Janice Wai,
Jeanne A Young,
Jeffrey W Shrifter, DPM,
Jennifer S King,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Liu,
John Cheung,
John Fox,
Jolene S Hedgecock,
Joseph C Yen,
Joseph M Willems,
Joseph Tibay,
Juan A Morales,
Juliane Kjung Lau,
Justin M Runac,
Kacie M Crowther,
Karen D Phung,
Karen M Willis,
Karla J Gibler,
Kevin P Foley,
Kimberlee Wood,
Kimberly L Anderson,
Larkin R Buckalew,
Lealand Lee,
Ligia M Sanders,
Lija V Fellows,
Linda Linh N Adams,
Linda S Shook,
Lisa H Nakagawa,
Lorraine N Williams,
LT Mark A Chen, MPH,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Maridali Deleon Torres,
Marissa J Chan,
Mark E Baldwin,
Mark I Nakano,
Mark L Collins,
Mary R Hole,
Mcgrewp,
Melvin Dorin,
Michael D Kawalek,
Monique C Lo,
Ngoc B Kelsch,
Nianna C Burns,
Nympha V Florendo,
Peter E Baker,
Phung,
Quynh H Strandberg,
Randall J Plunkett,
Randall P Zielinski,
Ronald P Boyce,
Rumany C Penn, PharmD,
Siobhan A Gallagher,
Steve P Yost,
Steven J Branch,
Steven R Gillenwater,
Stuart W Russell,
Sylvia D Lynche,
Terrence Gee,
Thanh Thu T Huynh,
Thomas N Adjabeng,
Timothy C Grome,
Travelle D Mason,
Trusten J Robles,
Vi T Au,
Victoria L Morgan,
Wen Jun Peng,
William J Foust,
William J Weis
Raymond Souweha's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2002 | FDA 483 | Intensive Nutrition Incorporated - Form 483, 2002-10-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more